CME Information
Original Release: December 22, 2017
Expiration: December 31, 2018
This continuing medical education activity is jointly provided by New York Eye and Ear Infirmary of Mount Sinai and MedEdicus LLC.
This continuing medical education activity is supported through an unrestricted educational grant from Santen Pharmaceutical Co, Ltd.
FACULTY
Quan Dong Nguyen, MD, MSc (Chair)
Professor of Ophthalmology
Byers Eye Institute
Stanford University School of Medicine
Palo Alto, California
Thomas Albini, MD
Associate Professor of Clinical Ophthalmology
Bascom Palmer Eye Institute
University of Miami Miller School of Medicine
Miami, Florida
Sofia Androudi, MD
Assistant Professor
Regional General University Hospital of Larissa
Ophthalmology Clinic
Mezourlo Larissa, Greece
Sunil Srivastava, MD
Associate Professor of Ophthalmology
Cleveland Clinic
Cleveland, Ohio
CME REVIEWER FOR NEW YORK EYE AND EAR INFIRMARY OF MOUNT SINAI
Ronald C. Gentile, MD, FACS, FASRS
Professor of Ophthalmology
Icahn School of Medicine at Mount Sinai
Director, Ocular Trauma Service (Posterior Segment)
New York Eye and Ear Infirmary of Mount Sinai
New York, New York
LEARNING METHOD AND MEDIUM
This educational activity consists of a webinar and thirteen (13) study questions. The participant should, in order, read the learning objectives contained at the beginning of this webinar, view the webinar, answer all questions in the post test, and complete the Activity Evaluation/Credit Request form. To receive credit for this activity, please follow the instructions provided on the post test and Activity Evaluation/Credit Request form. This educational activity should take a maximum of 1.5 hours to complete.
CONTENT SOURCE
This continuing medical education (CME) activity captures content from a live expert panel symposium held on August 12, 2017, in Boston, Massachusetts. This CME symposium is not affiliated with the official program of ASRS 2017.
ACTIVITY DESCRIPTION
This activity presents an update on differential diagnosis of noninfectious uveitis of the posterior segment (NIU-PS) and current and emerging treatments for patients with NIU-PS that can be managed by the retina specialist who is not a uveitis specialist.
TARGET AUDIENCE
This educational activity is intended for retina specialists.
LEARNING OBJECTIVES
Upon completion of this activity, participants will be better able to:
- Use diagnostic criteria to accurately diagnose noninfectious uveitis of the posterior segment
- Describe which patients with noninfectious uveitis of the posterior segment would be referred to a uveitis specialist
- Review evidence-based systemic treatments for patients with noninfectious posterior uveitis
- Apply information on the mechanism of action and safety and efficacy data of emerging agents in clinical trials for local therapy to the management of patients with noninfectious uveitis of the posterior segment
ACCREDITATION STATEMENT
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of New York Eye and Ear Infirmary of Mount Sinai and MedEdicus LLC. The New York Eye and Ear Infirmary of Mount Sinai is accredited by the ACCME to provide continuing medical education for physicians.
In July 2013, the Accreditation Council for Continuing Medical Education (ACCME) awarded New York Eye and Ear Infirmary of Mount Sinai "Accreditation with Commendation," for six years as a provider of continuing medical education for physicians, the highest accreditation status awarded by the ACCME.
AMA CREDIT DESIGNATION STATEMENT
The New York Eye and Ear Infirmary of Mount Sinai designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
GRANTOR STATEMENT
This continuing medical education activity is supported through an unrestricted educational grant from Santen Pharmaceutical Co, Ltd.
DISCLOSURE POLICY STATEMENT
It is the policy of New York Eye and Ear Infirmary of Mount Sinai that the faculty and anyone in a position to control activity content disclose any real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). New York Eye and Ear Infirmary of Mount Sinai has established policies in place that will identify and resolve all conflicts of interest prior to this educational activity. Full disclosure of faculty/planners and their commercial relationships, if any, follows.
DISCLOSURES
Thomas Albini, MD, had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board: AbbVie Inc; Alcon; Allergan; Bausch & Lomb Incorporated; Beaver-Visitec International; Clearside Biomedical, Inc; DORC; Eleven Biotherapeutics; Genentech, Inc; F. Hoffmann-La Roche Ltd; Santen Pharmaceutical Co, Ltd; and UCB SA.
Sofia Androudi, MD, had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board: Allergan; Bayer AG; and Novartis AG; Contracted Research: AbbVie Inc; Alcon; F. Hoffmann-La Roche Ltd; and Novartis AG.
Quan Dong Nguyen, MD, MSc, had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board: Genentench, Inc; Regeneron Pharmaceuticals, Inc; and Santen Pharmaceutical Co, Ltd.
Sunil Srivastava, MD,had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board: Allergan; Bausch & Lomb Incorporated; Clearside Biomedical, Inc; Optos; pSivida;
Regeneron Pharmaceuticals, Inc; Santen Pharmaceutical Co, Ltd; and Zeiss; Contracted Research: Allergan; Bausch & Lomb Incorporated; pSivida; Sanofi; and Santen Pharmaceutical Co, Ltd.
NEW YORK EYE AND EAR INFIRMARY OF MOUNT SINAI PEER REVIEW DISCLOSURE
Ronald C. Gentile, MD, FACS, FASRS has no relevant commerical relationships to disclose. He is a PI or Sub-PI for Institutional Research funded by Alcon/Novartis AG; Allergan; Genentech, Inc.; and Regeneron Pharmaceuticals, Inc.
EDITORIAL SUPPORT DISCLOSURES
Cheryl Guttman; Melissa Carter-Ozhan; Diane McArdle, PhD; Cynthia Tornallyay, RD, MBA, CHCP; Kimberly Corbin, CHCP; Barbara Aubel; and Michelle Ong have no relevant commercial relationships to disclose.
DISCLOSURE ATTESTATION
The contributing physicians listed above have attested to the following:
- that the relationships/affiliations noted will not bias or otherwise influence their involvement in this activity;
- that practice recommendations given relevant to the companies with whom they have relationships/affiliations will be supported by the best available evidence or, absent evidence, will be consistent with generally accepted medical practice; and
- that all reasonable clinical alternatives will be discussed when making practice recommendations.
OFF-LABEL DISCUSSION
This CME activity includes discussion of unlabeled and/or investigative uses of drugs. Please refer to the official prescribing information for each drug discussed in this activity for FDA-approved dosing, indications, and warnings.
For Digital Editions
System Requirements:
If you are viewing this activity online, please ensure the computer you are using meets the following requirements:
-
Operating System: Windows or Macintosh
Media
- Viewing Requirements: Flash Player or Adobe Reader
- Supported Browsers: Microsoft Internet Explorer, Firefox, Google Chrome, Safari, and Opera
- A good Internet connection
New York Eye and Ear Infirmary of Mount Sinai Privacy & Confidentiality Policies
http://www.nyee.edu/health-professionals/cme/enduring-activities
CME Provider Contact Information
For questions about this activity, call 212-870-8127.
TO OBTAIN AMA PRA CATEGORY 1 CREDIT™
To obtain AMA PRA Category 1 Credit™ for this activity, read the material in its entirety and consult referenced sources as necessary; then complete the post test and evaluation online by going to https://tinyurl.com/uveitis101. Upon passing, you will receive your certificate immediately. You must score 70% or higher to receive credit for this activity, and may take the test up to 2 times. Upon registering and successfully completing the post test, your certificate will be made available online and you can print it or file it.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of New York Eye and Ear Infirmary of Mount Sinai, MedEdicus LLC, or Santen Pharmaceutical Co, Ltd.
This CME activity is copyrighted to MedEdicus LLC© 2017. All rights reserved.